Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
6.61
-0.24 (-3.50%)
Aug 14, 2025, 2:16 PM - Market open
Fulcrum Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Cash & Equivalents | 42.59 | 58.21 | 25.56 | 35.1 | 35.41 | 57.05 | Upgrade
|
| Short-Term Investments | 171.52 | 182.81 | 210.66 | 167.82 | 182.75 | 55.86 | Upgrade
|
| Cash & Short-Term Investments | 214.11 | 241.02 | 236.22 | 202.92 | 218.16 | 112.91 | Upgrade
|
| Cash Growth | -21.79% | 2.03% | 16.41% | -6.99% | 93.21% | 16.75% | Upgrade
|
| Accounts Receivable | - | 2.1 | 0.54 | 0.23 | 3.64 | 2.53 | Upgrade
|
| Other Receivables | 1.33 | 1.25 | 1.71 | 0.85 | 0.47 | 0.18 | Upgrade
|
| Receivables | 1.33 | 3.34 | 2.25 | 1.08 | 4.11 | 2.71 | Upgrade
|
| Prepaid Expenses | 3.93 | 5.56 | 3.73 | 3.52 | 3.73 | 3.82 | Upgrade
|
| Other Current Assets | - | - | - | - | - | 0.07 | Upgrade
|
| Total Current Assets | 219.37 | 249.92 | 242.2 | 207.52 | 226 | 119.51 | Upgrade
|
| Property, Plant & Equipment | 8.25 | 9.58 | 12.39 | 15.97 | 7.37 | 8.4 | Upgrade
|
| Other Long-Term Assets | 1.22 | 1.21 | 3.1 | 3.2 | 1.63 | 1.67 | Upgrade
|
| Total Assets | 228.84 | 260.72 | 257.69 | 226.69 | 235 | 129.58 | Upgrade
|
| Accounts Payable | 1.75 | 1.16 | 2.76 | 3.64 | 4.79 | 4.08 | Upgrade
|
| Accrued Expenses | 4.77 | 7.23 | 8.33 | 9.45 | 9.16 | 7.21 | Upgrade
|
| Current Portion of Leases | 2.29 | 2.19 | 2.19 | 2.6 | - | 0.02 | Upgrade
|
| Current Unearned Revenue | - | - | - | 0.93 | 4.71 | 14.91 | Upgrade
|
| Other Current Liabilities | 0.17 | 0.46 | 0.4 | 0.11 | 0.54 | 0.51 | Upgrade
|
| Total Current Liabilities | 8.99 | 11.04 | 13.68 | 16.73 | 19.2 | 26.73 | Upgrade
|
| Long-Term Leases | 5.28 | 6.44 | 8.63 | 10.82 | - | - | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | - | - | 2.97 | Upgrade
|
| Other Long-Term Liabilities | 0.2 | 0.2 | 0.2 | 0.2 | 4.26 | 4.7 | Upgrade
|
| Total Liabilities | 14.46 | 17.68 | 22.5 | 27.74 | 23.46 | 34.4 | Upgrade
|
| Common Stock | 0.05 | 0.05 | 0.06 | 0.05 | 0.04 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 768.59 | 762.25 | 744.94 | 612.03 | 514.36 | 316.78 | Upgrade
|
| Retained Earnings | -554.35 | -519.4 | -509.67 | -412.34 | -302.47 | -221.62 | Upgrade
|
| Comprehensive Income & Other | 0.08 | 0.13 | -0.14 | -0.8 | -0.4 | -0 | Upgrade
|
| Total Common Equity | 214.38 | 243.03 | 235.19 | 198.94 | 211.54 | 95.18 | Upgrade
|
| Shareholders' Equity | 214.38 | 243.03 | 235.19 | 198.94 | 211.54 | 95.18 | Upgrade
|
| Total Liabilities & Equity | 228.84 | 260.72 | 257.69 | 226.69 | 235 | 129.58 | Upgrade
|
| Total Debt | 7.57 | 8.63 | 10.82 | 13.42 | - | 0.02 | Upgrade
|
| Net Cash (Debt) | 206.54 | 232.39 | 225.4 | 189.5 | 218.16 | 112.9 | Upgrade
|
| Net Cash Growth | -21.80% | 3.10% | 18.95% | -13.14% | 93.24% | 16.79% | Upgrade
|
| Net Cash Per Share | 3.32 | 3.75 | 3.68 | 4.21 | 6.17 | 4.45 | Upgrade
|
| Filing Date Shares Outstanding | 54.09 | 53.98 | 61.94 | 61.76 | 40.63 | 32.55 | Upgrade
|
| Total Common Shares Outstanding | 54.09 | 53.97 | 61.92 | 52.1 | 40.63 | 27.94 | Upgrade
|
| Working Capital | 210.39 | 238.88 | 228.52 | 190.79 | 206.8 | 92.79 | Upgrade
|
| Book Value Per Share | 3.96 | 4.50 | 3.80 | 3.82 | 5.21 | 3.41 | Upgrade
|
| Tangible Book Value | 214.38 | 243.03 | 235.19 | 198.94 | 211.54 | 95.18 | Upgrade
|
| Tangible Book Value Per Share | 3.96 | 4.50 | 3.80 | 3.82 | 5.21 | 3.41 | Upgrade
|
| Machinery | 10.9 | 10.84 | 10.68 | 10.24 | 9.15 | 7.84 | Upgrade
|
| Construction In Progress | - | - | - | 0.03 | - | 0.26 | Upgrade
|
| Leasehold Improvements | 7.12 | 7.12 | 7.1 | 7.1 | 6.29 | 6.21 | Upgrade
|
Updated Jul 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.